Literature DB >> 33534816

Heat-stability study of various insulin types in tropical temperature conditions: New insights towards improving diabetes care.

Beatrice Kaufmann1, Philippa Boulle2, Flavien Berthou3, Margot Fournier3, David Beran4, Iza Ciglenecki2, Malcolm Townsend2, Guillaume Schmidt2, Maya Shah2, Susanna Cristofani2, Philippe Cavailler2, Michelangelo Foti3, Leonardo Scapozza1.   

Abstract

Strict storage recommendations for insulin are difficult to follow in hot tropical regions and even more challenging in conflict and humanitarian emergency settings, adding an extra burden to the management of people with diabetes. According to pharmacopeia unopened insulin vials must be stored in a refrigerator (2-8°C), while storage at ambient temperature (25-30°C) is usually permitted for the 4-week usage period during treatment. In the present work we address a critical question towards improving diabetes care in resource poor settings, namely whether insulin is stable and retains biological activity in tropical temperatures during a 4-week treatment period. To answer this question, temperature fluctuations were measured in Dagahaley refugee camp (Northern Kenya) using log tag recorders. Oscillating temperatures between 25 and 37°C were observed. Insulin heat stability was assessed under these specific temperatures which were precisely reproduced in the laboratory. Different commercialized formulations of insulin were quantified weekly by high performance liquid chromatography and the results showed perfect conformity to pharmacopeia guidelines, thus confirming stability over the assessment period (four weeks). Monitoring the 3D-structure of the tested insulin by circular dichroism confirmed that insulin monomer conformation did not undergo significant modifications. The measure of insulin efficiency on insulin receptor (IR) and Akt phosphorylation in hepatic cells indicated that insulin bioactivity of the samples stored at oscillating temperature during the usage period is identical to that of the samples maintained at 2-8°C. Taken together, these results indicate that insulin can be stored at such oscillating ambient temperatures for the usual four-week period of use. This enables the barrier of cold storage during use to be removed, thereby opening up the perspective for easier management of diabetes in humanitarian contexts and resource poor settings.

Entities:  

Year:  2021        PMID: 33534816      PMCID: PMC7857579          DOI: 10.1371/journal.pone.0245372

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  34 in total

1.  Evaluation of non-isothermal methods in stability studies of human insulin pharmaceutical preparations.

Authors:  Alexis Oliva; Marta Suárez; Juan Ramón Hernández; Matías Llabrés; José B Fariña
Journal:  J Pharm Biomed Anal       Date:  2009-01-24       Impact factor: 3.935

2.  A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin (despentapeptide insulin).

Authors:  J Brange; G G Dodson; D J Edwards; P H Holden; J L Whittingham
Journal:  Proteins       Date:  1997-04

3.  Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: an in vitro stability assessment.

Authors:  Marieke Veurink; Cinzia Stella; Cyrus Tabatabay; Constantin J Pournaras; Robert Gurny
Journal:  Eur J Pharm Biopharm       Date:  2010-12-21       Impact factor: 5.571

4.  Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis.

Authors:  Sanjay Basu; John S Yudkin; Sylvia Kehlenbrink; Justine I Davies; Sarah H Wild; Kasia J Lipska; Jeremy B Sussman; David Beran
Journal:  Lancet Diabetes Endocrinol       Date:  2018-11-21       Impact factor: 32.069

5.  The enhancing effect of homocysteine thiolactone on insulin fibrillation and cytotoxicity of insulin fibril.

Authors:  Reza Yousefi; Shima Jalili; Parnian Alavi; Ali-Akbar Moosavi-Movahedi
Journal:  Int J Biol Macromol       Date:  2012-05-23       Impact factor: 6.953

6.  Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems.

Authors:  Bruno Sarmento; António Ribeiro; Francisco Veiga; Domingos Ferreira
Journal:  Biomed Chromatogr       Date:  2006-09       Impact factor: 1.902

Review 7.  Diabetes care in sub-Saharan Africa.

Authors:  David Beran; John S Yudkin
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

8.  Insulin analog with additional disulfide bond has increased stability and preserved activity.

Authors:  Tine N Vinther; Mathias Norrman; Ulla Ribel; Kasper Huus; Morten Schlein; Dorte B Steensgaard; Thomas Å Pedersen; Ingrid Pettersson; Svend Ludvigsen; Thomas Kjeldsen; Knud J Jensen; František Hubálek
Journal:  Protein Sci       Date:  2013-01-17       Impact factor: 6.725

9.  Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption.

Authors:  Nicolas Calo; Pierluigi Ramadori; Cyril Sobolewski; Yannick Romero; Christine Maeder; Margot Fournier; Pia Rantakari; Fu-Ping Zhang; Matti Poutanen; Jean-François Dufour; Bostjan Humar; Serge Nef; Michelangelo Foti
Journal:  Gut       Date:  2016-05-24       Impact factor: 23.059

10.  Use of a small peptide fragment as an inhibitor of insulin fibrillation process: a study by high and low resolution spectroscopy.

Authors:  Victor Banerjee; Rajiv K Kar; Aritreyee Datta; Krupakar Parthasarathi; Subhrangsu Chatterjee; Kali P Das; Anirban Bhunia
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

View more
  2 in total

1.  Diabetes Technology Meeting 2021.

Authors:  Nicole Y Xu; Kevin T Nguyen; Ashley Y DuBord; John Pickup; Jennifer L Sherr; Hazhir Teymourian; Eda Cengiz; Barry H Ginsberg; Claudio Cobelli; David Ahn; Riccardo Bellazzi; B Wayne Bequette; Laura Gandrud Pickett; Linda Parks; Elias K Spanakis; Umesh Masharani; Halis K Akturk; John S Melish; Sarah Kim; Gu Eon Kang; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2022-05-02

2.  Chronic NCD care in crises: A qualitative study of global experts' perspectives on models of care for hypertension and diabetes in humanitarian settings.

Authors:  Éimhín Ansbro; Rita Issa; Ruth Willis; Karl Blanchet; Pablo Perel; Bayard Roberts
Journal:  J Migr Health       Date:  2022-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.